Record #30769
Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study
Journal
Publisher
Original paper date
Dec 28, 2007
Original DOI
Country
Open access
No
Article type
Notes from Retraction Watch
date of retraction unknown, html page overwrite, estimated from notifications; journal previously pubbed by Wiley;
Citation lifecycle
How this paper is being cited
Pre-retraction
60
Same day
0
Post-retraction
4
% post-retraction
6.3%
~4.4 citations/yr before retraction · ~0.8 citations/yr after
— citing papers
Who is still citing this work
Loading…